American Journal of Preventive Medicine
Volume 33, Issue 5 , Pages 428-434.e11 , November 2007

Trials of Decision Aids for Prostate Cancer Screening: A Systematic Review

  • Robert J. Volk, PhD

      Affiliations

    • Department of Family and Community Medicine, Baylor College of Medicine, Houston, Texas
    • Houston Center for Education and Research on Therapeutics, Baylor College of Medicine, Houston, Texas
    • Corresponding Author InformationAddress correspondence and reprint requests to: Robert J. Volk, PhD, Department of Family and Community Medicine, Baylor College of Medicine, 3701 Kirby Dr., Suite 600, Houston TX 77098-3915.
    • ,
  • Sarah T. Hawley, PhD

      Affiliations

    • Division of General Medicine, Ann Arbor Veterans’ Affairs Medical Center, University of Michigan, Ann Arbor, Michigan
    • ,
  • Suzanne Kneuper, MA

      Affiliations

    • Department of Family and Community Medicine, Baylor College of Medicine, Houston, Texas
    • ,
  • E. Wayne Holden, PhD

      Affiliations

    • Macro International Inc., Atlanta, Georgia
    • ,
  • Leonardo A. Stroud, MD, MPH

      Affiliations

    • Division of Cancer Prevention and Control, Epidemiology and Applied Research Branch, Centers for Disease Control and Prevention, Atlanta, Georgia
    • ,
  • Crystale Purvis Cooper, PhD

      Affiliations

    • Soltera Center for Health Communication Research, Tucson, Arizona
    • ,
  • Judy M. Berkowitz, PhD

      Affiliations

    • Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia
    • ,
  • Lawrence E. Scholl, MPH

      Affiliations

    • Macro International Inc., Atlanta, Georgia
    • ,
  • Smita S. Saraykar, MBBS, MPH

      Affiliations

    • Department of Family and Community Medicine, Baylor College of Medicine, Houston, Texas
    • ,
  • Valory N. Pavlik, PhD

      Affiliations

    • Department of Family and Community Medicine, Baylor College of Medicine, Houston, Texas

References 

  1. American Cancer Society. Cancer Facts and Figures 2002. Atlanta, Georgia 2002 Available online at: www.cancer.org.
  2. Harris R, Lohr KN. Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:917–929
  3. American Urological Association (AUA). Prostate-specific antigen (PSA) best practice policy. Oncology (Williston Park). 2000;14:267–272277–8, 280 passim
  4. Screening for prostate cancer: recommendation and rationale. Ann Intern Med. 2002;137:915–916
  5. American Academy of Family Physicians. Summary of policy recommendations for periodic health examinations, revision 5.4. Leawood KS: American Academy of Family Physicians; 2003;
  6. Briss P, Rimer B, Reilley B, et al. Promoting informed decisions about cancer screening in communities and healthcare systems. Am J Prev Med. 2004;26:67–80
  7. Ferrini R, Woolf SH American College of Preventive Medicine practice policy. Screening for prostate cancer in American men. Am J Prev Med. 1998;15:81–84
  8. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society guidelines for the early detection of cancer, 2005. CA Cancer J Clin. 2005;55:31–44
  9. Barry MJ. Health decision aids to facilitate shared decision making in office practice. Ann Intern Med. 2002;136:127–135
  10. O’Connor AM, Stacey D, Rovner D, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2003;3:CD001431
  11. Trevena L, Barratt A. Integrated decision making: definitions for a new discipline. Patient Educ Couns. 2003;50:265–268
  12. Evans R, Edwards A, Brett J, et al. Reduction in uptake of PSA tests following decision aids: systematic review of current aids and their evaluations. Patient Educ Couns. 2005;58:13–26
  13. Whelan TM, O’Brien MA, Villasis-Keever M, et al. Impact of cancer-related decision aids. evidence report/technology assessment Number 46. AHRQ Publication No. 02-E004 Rockville MD: Agency for Healthcare Research and Quality; 2002;July
  14. Zaza S, Carande-Kulis VG, Sleet DA, et al. Methods for conducting systematic reviews of the evidence of effectiveness and economic efficiency of interventions to reduce injuries to motor vehicle occupants. Am J Prev Med. 2001;21(4S):23–30
  15. Frosch DL, Kaplan RM, Felitti V. The evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test. J Gen Intern Med. 2001;16:391–398
  16. Partin MR, Nelson D, Radosevich D, et al. Randomized trial examining the effect of two prostate cancer screening educational interventions on patient knowledge, preferences, and behaviors. J Gen Intern Med. 2004;19:835–842
  17. Frosch DL, Kaplan RM, Felitti VJ. A randomized controlled trial comparing Internet and video to facilitate patient education for men considering the prostate specific antigen test. J Gen Intern Med. 2003;18:781–787
  18. Taylor KL, Davis JL, Turner RO, et al. Educating African American men about the prostate cancer screening dilemma: a randomized intervention. Cancer Epidemiol Biomarkers Prev. 2006;15:2179–2188
  19. Sheridan SL, Felix K, Pignone MP, Lewis CL. Information needs of men regarding prostate cancer screening and the effect of a brief decision aid. Patient Educ Couns. 2004;54:345–351
  20. Schapira MM, Meade C, Nattinger AB. Enhanced decision-making: the use of a videotape decision-aid for patients with prostate cancer. Patient Educ Couns. 1997;30:119–127
  21. Hammond CS, Wasson JH, Walker-Corkery E, Fowler FJ, Barry MJ. A frequently used patient and physician-directed educational intervention does nothing to improve primary care of prostate conditions. Urology. 2001;58:875–881
  22. Flood AB, Wennberg JE, Nease RF, Fowler FJ, Ding J, Hynes LM. The importance of patient preference in the decision to screen for prostate cancer (Prostate Patient Outcomes Research Team). J Gen Intern Med. 1996;11:342–349
  23. Volk RJ, Cass AR, Spann SJ. A randomized controlled trial of shared decision making for prostate cancer screening. Arch Fam Med. 1999;8:333–340
  24. Volk RJ, Spann SJ, Cass AR, Hawley ST. Patient education for informed decision making about prostate cancer screening: a randomized controlled trial with 1-year follow-up. Ann Fam Med. 2003;1:22–28
  25. Gattellari M, Ward JE. Does evidence-based information about screening for prostate cancer enhance consumer decision-making? (A randomised controlled trial). J Med Screen. 2003;10:27–39
  26. Myers RE, Daskalakis C, Cocroft J, et al. Preparing African-American men in community primary care practices to decide whether or not to have prostate cancer screening. J Natl Med Assoc. 2005;97:1143–1154
  27. Watson E, Hewitson P, Brett J, et al. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men’s knowledge, attitudes and intention to be tested. Patient Educ Couns. 2006;63:367–379
  28. Wilkins EG, Lowery JC, Hamill JB. The impact of shared decision-making in prostate specific antigen (PSA) screening. Med Decis Making. 1996;19:525
  29. Wolf AM, Nasser JF, Schorling JB. The impact of informed consent on patient interest in prostate-specific antigen screening. Arch Intern Med. 1996;156:1333–1336
  30. Gattellari M, Ward JE. A community-based randomised controlled trial of three different educational resources for men about prostate cancer screening. Patient Educ Couns. 2005;57:168–182
  31. Myers RE, Chodak GW, Wolf TA, et al. Adherence by African American men to prostate cancer education and early detection. Cancer. 1999;86:88–104
  32. Ruthman JL, Ferrans CE. Efficacy of a video for teaching patients about prostate cancer screening and treatment. Am J Health Promot. 2004;18:292–295
  33. Schapira MM, VanRuiswyk J. The effect of an illustrated pamphlet decision-aid on the use of prostate cancer screening tests. J Fam Pract. 2000;49:418–424
  34. Davison BJ, Kirk P, Degner LF, Hassard TH. Information and patient participation in screening for prostate cancer. Patient Educ Couns. 1999;37:255–263
  35. Wilt TJ, Paul J, Murdoch M, Nelson D, Nugent S, Rubins HB. Educating men about prostate cancer screening (A randomized trial of a mailed pamphlet). Eff Clin Pract. 2001;4:112–120
  36. Foundation for Informed Medical Decision Making. The PSA decision: what YOU need to know. Developed by the Foundation for Informed Medical Decision Making and Distributed by Health Dialog, Inc. Available online at: www.healthdialog.com.
  37. O’Dell KJ, Volk RJ, Cass AR, Spann SJ. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?. J Fam Pract. 1999;48:682–688
  38. Radosevich DM, Partin MR, Nugent S, et al. Measuring patient knowledge of the risks and benefits of prostate cancer screening. Patient Educ Couns. 2004;54:143–152
  39. O’Connor AM. Validation of a decisional conflict scale. Med Decis Making. 1995;15:25–30
  40. Degner LF, Sloan JA, Venkatesh P. The control preferences scale. Can J Nurs Res. 1997;29:21–43
  41. Holmes-Rovner M, Kroll J, Schmitt N, et al. Patient satisfaction with health care decisions: the satisfaction with decision scale. Med Decis Making. 1996;16:58–64
  42. Ferrans CE, Powers MJ, Kasch CR. Satisfaction with health care of hemodialysis patients. Res Nurs Health. 1987;10:367–374
  43. Spielberger CD. State–Trait Anxiety Inventory for Adults Form Y: Review Set Manual, Test, Scoring Key. Redwood City CA: Mind Garden, Inc; 1983;
  44. Purvis Cooper C, Merritt TL, Ross LE, John LV, Jorgensen CM. To screen or not to screen, when clinical guidelines disagree: primary care physicians’ use of the PSA test. Prev Med. 2004;38:182–191
  45. Paasche-Orlow MK, Parker RM, Gazmararian JA, Nielsen-Bohlman LT, Rudd RR. The prevalence of limited health literacy. J Gen Intern Med. 2005;20:175–184
  46. Pignone M, DeWalt DA, Sheridan S, Berkman N, Lohr KN. Interventions to improve health outcomes for patients with low literacy (A systematic review). J Gen Intern Med. 2005;20:185–192
  47. Schwartz LM, Woloshin S, Fowler FJ, Welch HG. Enthusiasm for cancer screening in the United States. JAMA. 2004;291:71–78
  48. Ransohoff DF, McNaughton Collins M, Fowler FJ. Why is prostate cancer screening so common when the evidence is so uncertain? (A system without negative feedback). Am J Med. 2002;113:663–667
  49. Whitney SN. A new model of medical decisions: exploring the limits of shared decision making. Med Decis Making. 2003;23:275–280

PII: S0749-3797(07)00497-7

doi: 10.1016/j.amepre.2007.07.030

American Journal of Preventive Medicine
Volume 33, Issue 5 , Pages 428-434.e11 , November 2007

Article Tools